Clinical
Scenario:
- New-onset heart failure of >2 weeks’ duration associated with a normal-sized or dilated left ventricle and hemodynamic compromise
- New-onset heart failure of 2 weeks’ to 3 months’ duration associated with a dilated left ventricle and new ventricular arrhythmias, second- or third-degree heart block, or failure to respond to usual care within 1 to 2 weeks
- Heart failure of >3 months’ duration associated with a dilated left ventricle and new ventricular arrhythmias, second- or third-degree heart block, or failure to respond to usual care within 1 to 2 weeks
- Heart failure associated with a DCM of any duration associated with suspected allergic reaction and/or eosinophilia
- Heart failure associated with suspected anthracycline cardiomyopathy
- Heart failure associated with unexplained restrictive cardiomyopathy
- Suspected cardiac tumor
- Unexplained cardiomyopathy in children
- New-onset heart failure of 2 weeks’ to 3 months’ duration associated with a dilated left ventricle, without new ventricular arrhythmias or second- or third-degree heart block, that responds to usual care within 1 to 2 weeks
- Heart failure of >3 months’ duration associated with a dilated left ventricle, without new ventricular arrhythmias or second- or third-degree heart block, that responds to usual care within 1 to 2 weeks
- Heart failure associated with unexplained HCM
- Suspected ARVD/C
- Unexplained ventricular arrhythmias
- Among cardiac transplant recipients, is used routinely for analysis of rejection
